Cubist Systematic Strategies LLC Invests $85,000 in Waldencast plc (NASDAQ:WALD)

Cubist Systematic Strategies LLC purchased a new stake in Waldencast plc (NASDAQ:WALDFree Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 23,570 shares of the company’s stock, valued at approximately $85,000.

Other large investors have also added to or reduced their stakes in the company. Norden Group LLC bought a new stake in shares of Waldencast during the 1st quarter valued at $92,000. Catalina Capital Group LLC bought a new stake in Waldencast during the first quarter worth about $73,000. Bleakley Financial Group LLC bought a new stake in Waldencast during the first quarter worth about $142,000. Renaissance Technologies LLC acquired a new stake in Waldencast during the second quarter worth about $239,000. Finally, Marshall Wace LLP bought a new position in Waldencast in the 2nd quarter valued at about $37,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on WALD. Telsey Advisory Group reaffirmed an “outperform” rating and set a $6.00 price target on shares of Waldencast in a report on Wednesday, October 9th. DA Davidson upped their target price on Waldencast from $6.50 to $7.25 and gave the stock a “buy” rating in a research note on Wednesday, September 4th.

Get Our Latest Research Report on Waldencast

Waldencast Stock Performance

Waldencast stock opened at $3.46 on Wednesday. The company has a current ratio of 1.47, a quick ratio of 0.78 and a debt-to-equity ratio of 0.21. Waldencast plc has a 12-month low of $2.40 and a 12-month high of $12.00. The business’s 50-day moving average price is $3.43 and its two-hundred day moving average price is $4.06.

Waldencast Profile

(Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Further Reading

Want to see what other hedge funds are holding WALD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waldencast plc (NASDAQ:WALDFree Report).

Institutional Ownership by Quarter for Waldencast (NASDAQ:WALD)

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.